Cilo Cybin Pharmaceutical is currently planning to list on the JSE in the next 12 months and CEO Gabriel Theron joins Proactive London to discuss their plans which include the prospect of a dual listing in Europe or US.
The firm recently received the required certification from the South African Health Products Regulatory Authority which means it can produce marijuana for sale to consumers worldwide.